Join the conversation, follow our blogs and get up-to-the-minute news and health information from UK HealthCare.
Your destination for the latest news from UK HealthCare’s community engagement program.
September 15, 2014
Helping Extension help all of Kentucky
Read the blog »
Your student health clinic
September 2, 2014
Common Symptoms: Abdominal Pain
Nutrition for you
August 19, 2014
Leading the way for every patient, every time
September 10, 2014
UKudos to the Good Samaritan Second Floor OR Staff
A blog about the new facility, UK HealthCare at Turfland
September 19, 2014
Turfland construction continues at a great pace!
August 7, 2014
Rhinoplasty in Cleft Care
UK HealthCare patients have great stories to tell.
See more patient stories »
Call 859-257-1000 or 800-333-8874 for general info and appointments. Hours »
Call 859-323-5000 for patient information and hospital admin, 24/7.
Join us on social media for health tips and news, as well as the latest on UK HealthCare events. You can also help us give the very best care by sharing your feedback.
Take our quick survey and tell us what you think about our website »
LEXINGTON, Ky. (Sept. 23, 2014) — Good oral hygiene is especially important for pregnant women, who experience physiologic changes that can make teeth and gums more susceptible to disorders. An estimated 40 percent of pregnant women have a form of periodontal disease, and oral infections can put women at risk for adverse pregnancy outcomes.
Still, some obstetricians and dental care providers are often unclear about which practices and medications are safe for their prenatal patients.
"A lot of people think it's not safe to go to the dentist when you are pregnant, but in fact it's the opposite," Diana Frankenburger, childbirth education coordinator at UK HealthCare, said. "A lot of dentists are, frankly, nervous to provide some services to these patients."
On Sept. 23, a grand rounds session at the UK Chandler Hospital will join 150 oral health providers and obstetricians together for the first time to discuss best practices in prenatal oral health care. Dr. Julie McKee, the state dental director in the Kentucky Office of Health and Family Services, will present, "Oral Health Care: What's Appropriate and What Isn't During the Pre-Natal Period?" McKee will talk about safe oral treatment for prenatal patients with oral health disorders and the need to improve prenatal oral care in Kentucky. She will discuss guidelines provided by a consensus statement from the National Maternal and Child Oral Health Resource Center.
Frankenburger said often dentists and obstetricians have differing opinions about which types of treatment are appropriate for prenatal patients. The purpose of the grand round is to clarify information and encourage members of professions to recognize the beneficial relationship between obstetricians and dentists. McKee will also emphasize the importance of educating prenatal patients about the connection between good oral hygiene and a healthy pregnancy.
Dr. Pamela Sparks, associate dean for academic affairs in the UK College of Dentistry and a member of the Lexington-Fayette County Health Department board, said it's important for faculty within the college to stay current on the most relevant practices so they can not only practice those standards of care, but teach them to their students.
“The best care occurs when all members of the health care team are communicating and on the same page about appropriate care for their patients,” Sparks said.
The joint grand round is funded by a grant awarded to Lexington-Fayette County Health Department from the March of Dimes. Lexington Fayette County Health Department collaborates with the UK College of Dentistry and Bluegrass HealthFirst to provide dental services to women enrolled in the health department’s HANDS program, the Young Parents Program at the UK HealthCare Polk Dalton Clinic and the Centering Pregnancy and EMPOWR programs, which are both pregnancy assistance programs based at the UK HealthCare Polk Dalton Clinic. Pregnant women participating in these programs are provided with oral hygiene education and receive free oral care services.
MEDIA CONTACT: Elizabeth Adams, firstname.lastname@example.org
Following is a blog post from Janie Heath, dean and Warwick Professor of Nursing, University of Kentucky College of Nursing, a national leader in nursing education, tobacco control and health care outreach.
Sept. 19, 2014
CVS Health Stopping Sales of Tobacco Products
Why would a company in the business of health choose to sell products that so clearly destroy it?
Good question, admitted corporate executives at CVS Health, the nation’s second largest pharmacy chain. In a bold and courageous move, CVS Health executives announced this past February they would no longer sell, promote or carry tobacco products of any kind in any of their 7,700 stores (http://www.nytimes.com/2014/09/03/business/cvs-stores-stop-selling-all-tobacco-products.html?_r=0).
I’m happy to say that day is almost here — and a full month earlier than expected (http://www.npr.org/blogs/health/2014/09/03/345494727). I’d be even happier if their competitors were joining them in banning these products that are directly responsible for 450,000 senseless, preventable deaths every year. There’s no such luck at this point.
CVS Health says the company expects to lose $2 billion a year in sales but said its decision was the right thing to do. As for the rest of the pharmacy chain store industry, they appear to remain curiously quiet, at least for now.
Here’s hoping the drumbeat that CVS Health started in the retail pharmacy industry continues to get louder and that influencers in government, business and the culture itself will beat that same drum in their own spheres of influence. How can they not? Tobacco use is the single biggest cause of preventable illness and death in the nation. And the state with the highest percentage of adult smokers is our own — Kentucky.
In 2004, tobacco policy advocates at the University of Kentucky College of Nursing established The Kentucky Center for Smoke-Free Policy and began their own drumbeat, starting on the UK campus. By 2009, a campus-wide smoke-free policy was in effect. Today, all but two state universities have a smoke-free policy.
And the beat goes on. Last week, Kentucky Governor Steve Beshear announced that state-owned or leased buildings, vehicles and properties would be smoke-free starting in November. Currently, the ban only covers property controlled by the state’s executive branch of government. Kentucky’s judicial and legislative branches have the decision-making authority to march to their own drummers. Let’s hope it’s the right one.
Those of us who have devoted our professional careers to tobacco cessation research, intervention and public health policy are counting on companies like CVS Health and America’s public and private decision-makers, trendsetters and tastemakers to do the right thing. Tobacco companies are making a killing (literally) on a generation enslaved by a cruel addiction and they’re spending billions to come up with new products that may very well enslave the next. E-cigarettes? It’s “e-asy” to see how it could happen.
Still, we have something the tobacco companies don’t. We have the facts. When the Surgeon General’s landmark report on smoking and health was released in 1965, 42 percent of American adults were smokers. Today that percentage has dropped to 18 percent. Better, yes, but that’s small comfort to the 16 million Americans suffering from a smoking-related disease right this minute or a nation paying close to $300 billion in smoking-related health care costs (http://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/).
Still not hearing the drumbeat? Then hear this. An estimated 3,800 American children will try their first cigarette today. I, for one, am glad to know that soon they won’t be buying it (or having someone buy it for them) at CVS Health. How about you?
LEXINGTON, Ky. (Sept. 19, 2014) – Kentucky faces some of the highest rates of cancer incidence and mortality in the nation, but Methodist Hospital in Western Kentucky is stepping up the fight against cancer. The Methodist Hospital organization in Henderson, Ky., has announced a new affiliation with the University of Kentucky Markey Cancer Center, the state's first and only National Cancer Institute-designated cancer center.
Methodist Hospital CEO Bruce Begley said the announcement meant great things for their patients.
“The Methodist Hospital affiliation with the UK Markey Cancer Center brings to this region nationally ranked cancer treatment close to home," Begley said. "We believe this is a big step in the continuing battle against cancer, and I appreciate UK HealthCare's overall mission of extending high-quality cancer care to all Kentuckians.”
"We are extremely excited and proud for our cancer care program to become an affiliate of the Markey Cancer Center," said Dr. Arshad Husain, medical director of hematology and oncology at Methodist Hospital. "This alliance means great things for our patients. It will enable us to offer access to the latest practices in diagnosis and treatment of cancers and blood disorders, including clinical trials – thus providing a higher level of cancer care in our neighborhood."
The UK Markey Cancer Center Affiliate Network was created to provide high-quality cancer care closer to home for patients across the region, and to minimize the effects of cancer through prevention and education programs, exceptional clinical care, and access to research.
Methodist Hospital in Henderson is a 192-bed acute care facility and is just one facet of the Methodist Hospital Healthcare system. Other facilities serving the area include
Methodist Hospital Union County, a critical access hospital in nearby Morganfield, Ky., and 19 outpatient physician offices with 47 providers over a four-county service area.
By becoming a UK Markey Cancer Center Affiliate, Methodist Hospital is in keeping with the organization’s mission to provide safe, compassionate, high quality, and cost-effective services to the communities served. The Methodist Hospital Healthcare system will now be able to offer their patients access to additional specialty and subspecialty physicians and care, including clinical trials and advanced technology, while allowing them to stay in western Kentucky for most treatments.
The Markey Cancer Center Affiliate Network supports UK HealthCare's overall mission of ensuring no Kentuckian will have to leave the state to get access to top-of-the-line health care.
"UK HealthCare doesn't just serve Lexington and central Kentucky – our mission is to provide all Kentuckians with the best possible care right here in the state," said Dr. Michael Karpf, UK executive vice president for health affairs. "The Markey Cancer Center Affiliate Network allows us to collaborate with community hospitals to provide top-notch cancer care much closer to home -- saving both travel expenses and time for the patients, in addition to keeping them close to their personal support system."
Markey is one of only 68 medical centers in the country to earn an NCI cancer center designation. Because of the designation, Markey patients have access to new drugs, treatment options and clinical trials offered only at NCI centers.
Moving forward, the Markey Cancer Center is working toward the next tier of designation – an NCI-designated Comprehensive Cancer Center. Currently, 41 of the 68 NCI-designated cancer centers in the country hold a comprehensive cancer center status. The Markey Cancer Center Affiliate Network will play a large role in bringing that next level of cancer funding to Kentucky.
"The burden of cancer in Kentucky is huge, and unfortunately we have some of the worst cancer rates in the country," said Dr. Mark Evers, director of the UK Markey Cancer Center. "By collaborating with our affiliate hospitals across the state, we have the potential to make a serious impact on cancer care here in the Commonwealth."
The UK Markey Cancer Center Affiliate Network began in 2006 and comprises 12 hospitals across the state of Kentucky:
Evaluations are under way for several other hospitals, including two more outside the state of Kentucky, extending Markey's reach and establishing it as the destination cancer center for the region.
LEXINGTON, Ky. (Sept. 18, 2014) - To celebrate Ovarian Cancer Awareness Month, cancer survivors and UK faculty and staff participated in a special tailgating event called "tealgating" eariler this month.
The event further helped create awareness about the UK Ovarian Screening Program, an ongoing study that uses transvaginal ultrasound to detect ovarian cancers. Women over age 50 and women over age 25 who have a family history of ovarian cancer are eligible for the free program.
More than 43,000 women have participated in the UK Ovarian Screening Program and more than 256,000 free ultrasound screens have been done through the program. Women from every county in Kentucky have participated in the program ane more than 85 malignancies have been detected.
For more information on the program or to schedule an appointment, visit http://ovarianscreening.info.
LEXINGTON, Ky. (Sept. 17, 2014) — Praised as a poet of the keyboard, Israeli pianist Inon Barnatan will perform an interactive recital this weekend as part of the Sayklay Garbulinska Performer-in-Residence Series presented by the University of Kentucky Arts in HealthCare program.
The internationally celebrated musician was recently appointed as the New York Philharmonic's first Artist in Association, a position that spotlights an emerging artist with special appearances throughout several consecutive seasons.
UK performing arts students, musical students from local schools and the general public are invited to attend a free recital located in Pavilion A of the UK Albert B. Chandler Hospital at 2 p.m. on Sept. 21. Barnatan will accept questions from the audience on stage and meet with young musicians during a reception following the recital.
Born in 1979 in Tel Aviv, Barnatan's parents recognized his gift of perfect pitch at the age of 3. He has studied with piano maestri Victor Derevianko and at the London Royal Academy of Music under Maria Curcio and Christopher Elton. Since relocating to the United States in 2006, Barnatan has performed with the nation's most prestigious ensembles, including the Los Angeles Philharmonic and symphony orchestras of Atlanta, Dallas, Cincinnati, Cleveland, Houston, Philadelphia and San Francisco. He has performed at Carnegie Hall, the Lincoln Center and the Kennedy Center, among other famous venues. A highly sought chamber musician and soloist, he has appeared as a soloist with symphony orchestras in Jerusalem, Shanghai, London, Amsterdam, Germany, South Africa and Canada.
Barnatan is the Opening Night Guest Artist for the Lexington Philharmonic, which will present "Bolero and Barnatan" at the Singletary Center for the Arts on Sept. 20 to open the season titled "Pure Emotion." Barnatan joins LexPhil for Tchaikovsky’s iconic Piano Concerto No. 1. Gershwin’s Cuban Overture will complete the evening with Cuban rhythms, followed by French composer Ravel’s Alborada del gracioso and Bolero. Tickets range from $25 to $75, and are $11 for students, and can be purchased at www.lexphil.org or by calling (859) 233-4226.
To attend the free recital on Sept. 21, please RSVP to email@example.com or (859) 323-9896.
MEDIA CONTACT: Elizabeth Adams, firstname.lastname@example.org
LEXINGTON, Ky. (Sept. 16, 2014) – Dr. Edward M. Wolin, a nationally known expert in treating neuroendocrine and carcinoid tumors, has joined the team at the University of Kentucky Markey Cancer Center.
Neuroendocrine tumors develop from endocrine cells found in the digestive tract, lungs, pancreas, and other sites. These rare cancers present unique diagnostic challenges. They tend to be slow-growing, and usually have metastatic disease at the time of diagnosis.
At Markey, Wolin will serve as the director of the Carcinoid and Neuroendocrine Tumor Program. In addition to working with Markey's team of surgical and radiation oncologists, pathologists, and diagnostic radiologists, Wolin will collaborate on patient care with UK Chief of Medical Oncology Dr. Lowell Anthony. Anthony came to UK in 2011 and helped build up Markey's Neuroendocrine Clinic, the region's first multidisciplinary clinic dedicated to endocrine and neuroendocrine tumors.
Wolin brings a robust research program to Markey, including multiple clinical trials. His research efforts focus on finding treatments which are more effective and less toxic, including pasireotide, lanreotide, everolimus, other m-tor inhibitors, targeted radiation including peptide receptor radiotherapy with Lu-177, anti-angiogenic drugs, novel targeted biologic anti-cancer treatments, and targeted treatment of liver metastases. Wolin's research is also directed at development of new imaging and diagnostic procedures for carcinoid/neuroendocrine tumors.
"Dr. Wolin is renowned for his skill in treating these complex forms of cancer, and we are thrilled to bring his expertise to our patients here in Kentucky," said Dr. Mark Evers, director of the UK Markey Cancer Center. "Through his clinical trials, many patients will be able to receive extremely specialized care that they couldn't get anywhere else in the country."
Wolin earned his medical degree at Yale University School of Medicine. He performed his internship, residency and a medical oncology fellowship at Stanford University Medical Center followed by a clinical fellowship at the National Cancer Institute in Bethesda, Maryland. Prior to coming to Markey, he served as co-director of the Cedars-Sinai Carcinoid and Neuroendocrine Tumor Program at Cedars-Sinai Medical Center in Los Angeles.
Wolin sees patients in the Multidisciplinary Clinic on the first floor of the UK Markey Cancer Center's Whitney-Hendrickson building. To make an appointment, call 859-257-4488 or toll free 866-340-4488.
MEDIA CONTACT: Allison Perry, (859) 323-2399 or email@example.com
LEXINGTON, Ky. (Sept. 15, 2014) – A new study by University of Kentucky researchers has identified a novel molecule named Arylquin 1 as a potent inducer of Par-4 secretion from normal cells. Par-4 is a protein that acts as a tumor suppressor, killing cancer cells while leaving normal cells unharmed.
Normal cells secrete small amounts of Par-4 on their own, but this amount is not enough to kill cancer cells. Notably, if Par-4 secretion is suppressed, this leads to tumor growth.
Published in "Nature Chemical Biology," the UK study utilized lab cultures and animal models to show that low levels of Arylquin 1 induced Par-4 secretion without causing harm to the producer cells.
Additionally, researchers found that Par-4 is bound to a protein called vimentin, which contributes to tumor metastasis. Arylquin 1 binds to vimentin, displacing the Par-4 for secretion -- which means it may also be useful for inhibitiing the spread of cancer.
These findings have strong implications for the development of future cancer treatments, as researchers are now focusing on developing Arylquin 1 into a drug to inhibit both primary and metastatic tumors.
"We found that Par-4 is inactivated by pro-metastasis proteins such as vimentin," said Vivek Rangnekar, UK professor and Alfred Cohen Chair in Oncology Research in the Department of Radiation Medicine. "This implies that by using small molecule drugs that target metastasis proteins, we may be able to both inhibit the spread of cancer while also releasing the tumor suppressor -- Par-4 -- to then induce the death of the cancerous cells."
Rangnekar, who also serves as associate director for the UK Markey Cancer Center, initially discovered the Par-4 gene in 1994. Working closely with UK medicinal chemist David Watt and a multidisciplinary team across the UK campus, their labs are developing secretagogues that can cause elevated secretion of Par-4 for the inhibition of primary and metastatic tumors.
This study was funded by grants from the National Cancer Institute, the National Center for Research Resources, and the UK Center for Clinical and Translational Science.
LEXINGTON, Ky. (Sept. 15, 2014) -- Did you know that you can help others by participating in research? Health-focused research affects every aspect of our lives, from the medications we take to the health of our environment. Researchers are working hard to identify new treatments and strategies to improve the health of our communities, but research needs healthy volunteers and volunteers with medical conditions in order to succeed. Participating in research is a safe, easy way for you to give back to your community and give hope for the future while learning more about your own health.
Find out how you can participate in research during the University of Kentucky's next #AskACat Twitter chat, beginning 2 p.m. Tuesday, Sept. 16, at @universityofky. UK researchers will answer general questions about participating in research. They will also answer questions about ResearchMatch, a registry that pairs volunteers with researchers looking for participants, and UK's new Research Registry and Specimen Bank, or the "biobank." For more information on ResearchMatch, visit www.researchmatch.org/?rm=@AskaCat.
UK patients are being invited to help researchers by allowing leftover blood and tissue from their normal medical procedures to put into the biobank. For example, when a patient undergoes a blood draw or tissue biopsy, the blood or tissue that isn’t used for testing is normally thrown away. In the new biobank project, however, patients will be given a consent form to allow any “leftover” blood or tissue from their regular medical procedures to be stored in the biobank for research purposes. No additional procedures will be performed or extra blood or tissues collected whatsoever. Participation is voluntary, and to protect patient privacy, all identifying information (such as name, address and social security numbers) will be removed from the samples and corresponding medical records.
Four UK experts will respond to questions during the chat:
· Belinda Smith, education specialist at the Office of Research Integrity;
· Ada Sue Selwitz, director of the Office of Research Integrity;
· Dr. Susanne Arnold, associate professor in medical oncology and radiation medicine and associate director for clinical translation at the Markey Cancer Center; and
· Dr. Phil Kern, director of the Center for Clinical and Translational Science and the Barnstable Brown Diabetes and Obesity Center.
Join the conversation or follow the chat at the university's official account @universityofky, or use the hashtag #AskACat for questions and responses from the Twitter chat.
Individuals interested in asking questions about participation in health care research, ResearchMatch, or the biobank can send their questions to twitter.com/universityofky through 3 p.m. Sept. 16, or to the UK Facebook page prior to 2 p.m., Sept. 16. Responses to questions will be shared with the university's Twitter followers and those following the hashtag #AskACat.
UK will present its next #AskACat Twitter chat Oct. 21.
MEDIA CONTACT: Whitney Hale or Elizabeth Adams, 859-257-1754
LEXINGTON, Ky. (Sept. 12, 2014) - For the first time in Kentucky’s history, two nurse practitioners have been awarded the 2014 AANP (American Association of Nurse Practitioners) State Award for Excellence, and both are with the University of Kentucky/UK HealthCare. Audrey Darville, assistant professor with the College of Nursing, family nurse practitioner and certified tobacco treatment specialist, and Vicky Turner, codirector of the Center for Advanced Practice and acute care nurse practitioner with UK HealthCare Critical Care Cardiology, were both honored recently at the national AANP Annual Conference in Nashville.
The AANP Award for Excellence is given to a dedicated nurse practitioner who demonstrates excellence in their area of practice. With special permission from AANP two awards were presented this year.
Pictured left to right are: Kathy Wheeler, state representative to AANP, Turner, Darville and Kenneth Miller, AANP president.
The AANP (www.aanp.org) is the largest professional membership organization for nurse practitioners of all specialties. It represents the interests of the nation’s 189,000 nurse practitioners, including more than 50,000 members, providing a unified networking platform, and advocating for their role as providers of high-quality, cost-effective, comprehensive, patient-centered and personalized health care. The organization provides legislative leadership at the local, state and national levels, advancing health policy, promoting excellence in practice, education and research, and establishing standards that best serve nurse practitioner patients and other health care consumers.
Media Contact: Ann Blackford at 859-323-6442 or firstname.lastname@example.org
LEXINGTON, Ky. (Sept. 10, 2014) — Visionaries in the health care industry will take stages on the East Coast and the West Coast during this week's TEDMED 2014 Conference, but University of Kentucky students and faculty can stay on campus for a front-row seat.
The University of Kentucky American Medical Association (AMA) student section recently received a grant from the AMA to stream sessions from the annual conference to an audience of health care students and faculty members representing many health care disciplines. The chapter will play recorded sessions in Pavilion H of the UK Chandler Hospital on Thursday and Friday evenings, and throughout the day on Saturday. After each 90-minute session, a panel of UK HealthCare experts will discuss the main messages of the talks and how those messages relate to their experiences at UK. The sessions are open to all health profession students, including students in the colleges of public health, dentistry, nursing and pharmacy, as well as any interested hospital faculty.
Dually hosted in San Francisco and Washington, D.C., the TEDMED 2014 conference comprises a series of short, provocative talks and performances from a variety of thought-leaders, activists, artists, authors, physicians, researchers and other stakeholders in the health care industry. Each talk or performance will range from 8 to 20 minutes. Presenters will discuss a variety of topics, including solutions for today's health care problems from other worlds, new bedside eye-tracking devices to diagnose brain injuries, the economics behind drug addiction and a photographer's use of humor as therapy during his wife's cancer treatment. The goal of the conference is to inspire thought, expand worldviews and challenge old ways of thinking in health care professionals. The conference runs from Sept. 10-12.
Brad St. Martin, a second-year medical student and vice president of the UK AMA student section, thinks it's important for students to step away from their day-to-day study routine and expose themselves to different views and innovations in the health care profession. He encourages students from all five UK health colleges to attend the sessions.
"I am just hoping this will act as a forum for people to increase awareness of the bigger picture and current changes in health and medicine outside of their own fields," St. Martin said. "It's a change from the ordinary to help expand upon our ideas and inspire action."
Sessions will be held on Thursday and Friday from 5 to 7:15 p.m. On Saturday, two sessions will be held at 10 a.m. and 12 p.m. Light refreshments will be provided on Thursday and Friday and a light breakfast will be provided Saturday morning. All sessions will be held in HG611 in Pavilion H.
LEXINGTON, KY. (Sept. 9, 2014) — University of Kentucky Albert B. Chandler Hospital and Kentucky Children's Hospital have received their second straight Excellence in Life Support designation from the Extracorporeal Life Support Organization (ELSO) for neonatal, pediatric and adult patients.
The center of excellence designation gives the University of Kentucky Medical Center national recognition for providing outstanding care in Extracorporeal Life Support. ELSO also selected UK as one of only five centers to be presented as a Center of Excellence Award Winner at this year's ELSO conference in Ann Arbor, Mich.
The triple designation recognizes UK's commitment to using extracorporeal membrane oxygenation (ECMO) support for inpatients of all ages experiencing acute failure of the cardiorespiratory system. This technology can make the difference between life or death for patients whose heart and/or lungs are so severely damaged that they can no longer function.
Additionally, ECMO serves as a bridge to transplantation, allowing patients who are awaiting transplant to regain strength so they are physically able to undergo the complex surgery.
In 2013, UK supported 72 patients with a total of 14,185 hours of ECMO. UK began using ECMO in 1994, starting with neonatal patients before branching out to the pediatric and adult populations.
UK's adult ECMO team is led by Dr. Charles Hoopes, and the pediatric and neonatal ECMO team is led by Dr. Hubert Ballard. In order to provide this complex care, they are supported by teams from critical care medicine and pediatrics, neonatology, cardiothoracic surgery, pediatric surgery, perfusion, nursing, respiratory care and other ancillary services. This multidisciplinary team of UK HealthCare professionals collaborates to provide an outstanding level of care, underscoring the quality and commitment of the UK enterprise.
The Excellence in Life Support Award recognizes programs worldwide that distinguish themselves by having processes, procedures and systems in place that promote excellence and exceptional care in extracorporeal membrane oxygenation. To earn the designation, programs must promote the mission, activities, and vision of ELSO; demonstrate their ability to provide outstanding patient care by using the highest quality measures, processes, and structures based upon evidence; and excel in training, education, collaboration, and communication that supports ELSO guidelines and contributes to a healing environment.
Following is a blog from University of Kentucky College of Nursing Dean Janie Heath
Sept. 5, 2014
Dear Friends of the UK College of Nursing,
“A dream shared by many!” During the college’s 40th Anniversary celebration, this is what an excited Dr. Marcia A. Dake, the College of Nursing’s founding dean, recalled about the opening of the College. Indeed, the College has been a dream shared by many faculty, staff, students, deans, alumni and friends over the past 56 years. So it is with a deep sense of pride but also sadness that I write of Dr. Dake’s passing.
Her love of nursing began in high school where she assisted the high school nurse. Her education would follow the traditional nurse training path with a hospital diploma, after which she then entered the Army Nurse Corp in WWII. After the war, she completed her bachelor’s degree in public health nursing from Syracuse University and her master’s in education from Teacher’s College. A National League of Nurses fellowship allowed her to earn a PhD in education at Teacher’s College.
Dr. Carolyn Williams, dean emeritus of the College of Nursing, commented on Dr. Dake’s legacy. “Dr. Marcia Dake, nurse, educator and leader was a remarkable woman. She not only was the first dean of the College of Nursing (and the youngest dean of a nursing school at that time), she actually ‘built the college from scratch,’ hired the first faculty members, worked with them on designing the curriculum, and led them in planning for the first class of students, which began the nursing program in 1960.”
Those early years were a challenge for the dean in recruiting appropriately prepared faculty and developing a baccalaureate program in nursing which would be very different from traditional hospital diploma programs. The work paid off when the College earned its first accreditation in May 1965, which Dr. Dake said was indeed “a day of celebration.” By 1970, she and the faculty had earned approval for graduate education and welcomed the first class of master’s students.
In 1972, Dr. Dake left the University to become director of education for the American Nurses Association. Her nursing career later took her to a position at the American Red Cross and then she ended it by going full circle with another appointment as a founding dean of nursing at James Madison University in Harrisonburg, Va.
To honor Dr. Dake’s numerous contributions to our College and to the profession of nursing, the College’s first endowed professorship, made possible by the generosity of Linda and Jack Gill, was named in her honor.
Since her passing, I have been most fortunate to have had a number of fascinating conversations about Dr. Dake with faculty, alumni and staff in which they shared some of their recollections of the College’s first days as well as her absolute delight in the growth of the College’s programs and her faith in and commitment to its future.
Indeed, Dr. Dake was an amazing woman who was able to take that “dream shared by many” and forge it into reality - a reality that we continue to grow and strengthen today. We will be forever grateful for her leadership.
Dean and Warwick Professor of Nursing
University of Kentucky College of Nursing
LEXINGTON, Ky. (Sept. 8, 2014) — If you're grieving after a loved one died by suicide or attempted suicide, you don't have to suffer alone.
Many of us personally know someone who has died by or attempted suicide, but we don't really talk about it - suicide is scary, confusing, and stigmatized. The recent death of Robin Williams is a tragic reminder that mental illness and suicide don't discriminate, and that the grief associated with suicide loss is both sadly common and uniquely difficult to process.
Each year, approximately 39,000 Americans die by suicide. To put this into perspective, this is about the same number of Americans who die from breast cancer (about 40,000) and more than double the number are murdered (about 16,000).
In Kentucky, more than 650 lives are lost every year to suicide, which is the second leading cause of death for 15-24 years olds. A recent survey showed almost half of Kentuckians knew someone who had died by suicide.
Talking about your loss and your emotions can help you process what you're experiencing and can also help prevent future deaths by reducing stigma and offering hope and healing to the countless others who are affected by suicide.
Here are some things to keep in mind about coping with suicide loss:
Dr. Julie Cerel is a psychologist and associate professor in the UK College of Social Work and currently serves as Board Chair of the American Association of Suicidology.
MEDIA CONTACT: Mallory Powell, email@example.com
LEXINGTON, Ky. (Sept. 4, 2014) — A team of investigators has made a thought-provoking discovery about a type of cholesterol previously believed to be a "bad guy" in the development of heart disease and other conditions.
Jason Meyer, a University of Kentucky M.D.-Ph.D. candidate, worked with Deneys van der Westhuyzen, a professor in the departments of Internal Medicine and Molecular and Cellular Biochemistry, to study the role oxidized LDL plays in the development of plaque inside artery walls.
According to Meyer, the medical research community has traditionally believed that oxidized LDL plays a pivotal role in that process.
"Oxidized LDL moves rapidly into arterial walls and engorges them with cholesterol," Meyer said. "Cholesterol ultimately converts into plaque, blocking the arteries or, in a worst case scenario, rupturing and sending clots into the bloodstream, causing heart attacks and/or strokes."
However, more recent studies in animals and humans have brought that assumption into question, and the oxidized LDL theory is currently the subject of lively debate.
"Though in its very early stages, our research will add considerably to that controversy," Meyer said, "because it seems to indicate that oxidized LDL might, in fact, be a 'good guy' in the process."
The team's findings come from a project studying a pathway of cholesterol transport called "selective lipid uptake."
"Based on our analysis, we were surprised to find that, instead of increasing the amount of cholesterol uptake and accumulation in the macrophage foam cells, mildly oxidized LDL almost completely prevents increases in cholesterol," van der Westhuyzen said.
Meyer says the implications of the study are potentially profound.
"If it is demonstrated that oxidized LDL actually has a preventive effect on the accumulation of cholesterol in arterial walls, it may be possible to create a medicine from oxidized LDL to help prevent or treat this killer disease," Meyer said. "There is still much work to do because this project is very early in development and has not been tested in animals, but the results we have so far are very promising."
Meyer and van der Westhuyzen's findings were published in the August issue of the Journal of Lipid Research.
LEXINGTON, Ky. (Sept. 3, 2014) – Hardin Memorial Health celebrated a new affiliation between its Cancer Care Center and the University of Kentucky Markey Cancer Center, the state's first and only National Cancer Institute-designated cancer center.
"The Markey affiliate agreement provides a great opportunity for professional education and training for our staff and physicians," said Hardin Memorial Health President Dennis Johnson. "Collaboration with Markey and their affiliates across the state allows our team to stay up-to-date on the newest cancer treatments and research."
"There is no reason for cancer patients in central Kentucky to leave this area to seek treatment, because the HMH Cancer Care Center provides personalized cancer care close to home," said Dr. Adam Lye, medical director of the Hardin Memorial Health Cancer Care Center. "This care can be enhanced when combined with Markey's specialized treatment, technology and clinical trial opportunities that will help us take cancer care to the next level. This is great news for cancer patients and their families in our community."
By joining the UK Markey Cancer Center Affiliate Network, the HMH Cancer Care Center will be able to offer their patients access to additional specialty and subspecialty physicians and care, including clinical trials and advanced technology, while allowing them to stay closer to home for most treatments. The Markey Cancer Center Affiliate Network supports UK HealthCare's overall mission of ensuring no Kentuckian will have to leave the state to get access to top-of-the-line health care.
The UK Markey Cancer Center Affiliate Network began in 2006 and comprises eleven hospitals across the state of Kentucky:
1000 S. Limestone
800-333-8874 (toll free)
connected with UK HealthCare. Become a fan of our Facebook and follow us on
Twitter and Youtube to stay up-to-date on community events, programs,
treatments, research, new physicians and more.
© University of Kentucky, Lexington, Kentucky, USA | An Equal Opportunity University